GLP-1 medications may cause side effects including but not limited to nausea, vomiting, diarrhea, constipation, abdominal pain, headache, fatigue, and potential serious complications
Because Krystexxa is given intravenously, it would be expected that the great majority of its use would be by rheumatologists rather than by internists or primary care physicians
The HSP90AA1 protein, as a molecular chaperone, can bind to the HER2 protein to play an indirect role in BRCA pathogenesis
Also, GLP-1R agonists can protect the heart and kidneys, reduce the risk of cardiovascular events, and delay the progress of diabetic nephropathy, which is especially important for people with diabetes
At the molecular level, curcumin demonstrates the ability to regulate microRNA networks involved in the pathogenesis of DN
Most adults tolerate doses up to 500 mg per day without serious side effects